Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Review of sequencing platforms and their applications in phaeochromocytoma and paragangliomas.

Critical reviews in oncology/hematology - 1 Aug 2017

Pillai Suja, Gopalan Vinod, Lam Alfred King-Yin

Abstract excerpt

Genetic testing is recommended for patients with phaeochromocytoma (PCC) and paraganglioma (PGL) because of their genetic heterogeneity and heritability. Due to the large number of susceptibility genes associated with PCC/PGL, next-generation sequencing (NGS) technology is ideally suited for carrying out genetic screening of these individuals. New generations of DNA sequencing technologies facilitate the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Gland Neoplasms
Share to Biomarkers, Tumor
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to High-Throughput Nucleotide Sequencing

Share to Paraganglioma

Share to Pheochromocytoma

Share to Precision Medicine

Source

Identifiers

PMID: 28693800
DOI: 10.1016/j.critrevonc.2017.05.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Review of sequencing platforms and their applications in phaeochromocytoma and paragangliomas.PMID 28693800Read ↗

Next-generation sequencing for the diagnosis of hereditary pheochromocytoma and paraganglioma syndromesSemantic proximity Read ↗

Clinical exome next‑generation sequencing panel for hereditary pheochromocytoma and paraganglioma diagnosisSemantic proximity Read ↗

PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics.Semantic proximity Read ↗

Rethinking pheochromocytomas and paragangliomas from a genomic perspective.Semantic proximity Read ↗

Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas.Semantic proximity Read ↗

Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas.Semantic proximity Read ↗

Pheochromocytoma and paraganglioma: molecular testing and personalized medicine.Semantic proximity Read ↗

Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paragangliomaSemantic proximity Read ↗

Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paragangliomaSemantic proximity Read ↗

Clinical and molecular markers guide the genetics of pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Whole Exome Sequencing Identifies Novel Genetic Alterations in Patients with Pheochromocytoma/Paraganglioma.Semantic proximity Read ↗

Genetic bases of pheochromocytoma and paraganglioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.